Clipperton acted as sole financial advisor to Kinvent, the European leader in connected physiotherapy solutions, on its €16m growth financing led by Eurazeo Healthcare fund (Nov Santé), with the participation of existing minority shareholders including Unifund, Sofilaro, BADGE, and Raphaël Varane, among others.

This is the third round of fundraising and will enable the company to enter a new phase of acceleration, including market penetration in the United States in 2024 and increased effort on new R&D projects.